ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Long Term Durability of Bioprosthetic Aortic Valve Replacement in Young Patients With Bicuspid Aortic Stenosis

Thursday, August 8, 2024

Submitted by

Source

Source Name: JTCVS Structural and Endovascular

Author(s)

Christopher K. Mehta, Tom X. Liu, Abigail S. Baldridge, Jane Kruse, Jyothy Puthumana, Robert O. Bonow, Duc T. Pham, Douglas R. Johnston, S. Christopher Malaisrie, Patrick M. McCarthy

Treatment of aortic stenosis due to a bicuspid aortic valve (BAV), requires a lifetime strategy due to structural valve degeneration that necessitates redo intervention, such as surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). The researchers looked at outcomes for surgical valve replacement in patients with and without concomitant aortic aneurysms, and have reported excellent operative and reoperative outcomes, including durability at 10 years and valve function. The researchers make a case for performing surgical valve replacement versus TAVR in younger patients for several reasons, including the favorable operative and reoperative safety profile, ability to intervene on concomitant pathology (such as aneurysmal disease and atrial fibrillation), and established long-term durability profile. 
 

Add comment

Log in or register to post comments